219 related articles for article (PubMed ID: 21683387)
1. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.
Lange J; Peterson SM; Takashima JR; Grigoriev Y; Ritchey ML; Shamberger RC; Beckwith JB; Perlman E; Green DM; Breslow NE
J Urol; 2011 Aug; 186(2):378-86. PubMed ID: 21683387
[TBL] [Abstract][Full Text] [Related]
2. Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy.
Zirn B; Wittmann S; Gessler M
Am J Kidney Dis; 2005 Jun; 45(6):1100-4. PubMed ID: 15957141
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
5. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
6. Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant.
Falcone MP; Pritchard-Jones K; Brok J; Mifsud W; Williams RD; Nakata K; Tugnait S; Al-Saadi R; Side L; Anderson J; Duncan C; Marks SD; Bockenhauer D; Chowdhury T
Pediatr Nephrol; 2022 Apr; 37(4):821-832. PubMed ID: 34608521
[TBL] [Abstract][Full Text] [Related]
7. Bilateral Wilms tumor. Review of outcome, associated abnormalities, and late effects in 36 pediatric patients treated at a single institution.
Shearer P; Parham DM; Fontanesi J; Kumar M; Lobe TE; Fairclough D; Douglass EC; Wilimas J
Cancer; 1993 Aug; 72(4):1422-6. PubMed ID: 8393375
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
Heppe RK; Koyle MA; Beckwith JB
J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
10. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
[TBL] [Abstract][Full Text] [Related]
11. Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group.
Ritchey ML; Green DM; Thomas PR; Smith GR; Haase G; Shochat S; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Feb; 26(2):75-80. PubMed ID: 8531856
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
14. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
15. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
16. Wilms tumor: an update.
Al-Hussain T; Ali A; Akhtar M
Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
[TBL] [Abstract][Full Text] [Related]
17. Management of Wilms tumors in Drash and Frasier syndromes.
Auber F; Jeanpierre C; Denamur E; Jaubert F; Schleiermacher G; Patte C; Cabrol S; Leverger G; Nihoul-Fékété C; Sarnacki S
Pediatr Blood Cancer; 2009 Jan; 52(1):55-9. PubMed ID: 18816692
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
19. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.
Breslow NE; Collins AJ; Ritchey ML; Grigoriev YA; Peterson SM; Green DM
J Urol; 2005 Nov; 174(5):1972-5. PubMed ID: 16217371
[TBL] [Abstract][Full Text] [Related]
20. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
